Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

This publication has 9 references indexed in Scilit:

• Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
  Statistics in Biopharmaceutical Research, 2023
• Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
  The Lancet HIV, 2023
• Dicing with Death
  2022
• Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
  The Lancet HIV, 2017
• Why representativeness should be avoided
  International Journal of Epidemiology, 2013
• Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics
  Clinical Pharmacology & Therapeutics, 2000
• Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
  Clinical Pharmacokinetics, 1997
• Mortality in relation to smoking: 40 years' observations on male British doctors
  BMJ, 1994
• The Mortality of Doctors in Relation to Their Smoking Habits
  BMJ, 1954